Table 1.
siRNA | Gefitinib | T0901317 | Combination | SI | ||||
---|---|---|---|---|---|---|---|---|
MGI | P a | MGI | P a | Expectedb | Observedc | P a | ||
NC | 0.75 | < 0.001 | 0.88 | > 0.05 | 0.66 | 0.24 | < 0.001 | 2.75 |
siLXRα | 0.72 | < 0.001 | 0.85 | < 0.05 | 0.61 | 0.27 | < 0.001 | 2.26 |
siLXRβ | 0.83 | < 0.05 | 0.83 | < 0.05 | 0.69 | 0.65 | < 0.001 | 1.06 |
P value (two‐sided) was calculated by one‐way ANOVA compared with no treatment.
Expected growth inhibition rate = MGI T0901317 × MGI gefitinib.
Observed growth inhibition rate = growth inhibition rate of combined treatment/growth rate of untreated group.